CASE REPORT
Published on 08 Oct 2025
Case report: Anlotinib plus oral etoposide: a potential salvage therapy based on insights from EGFR-TKI-resistant SCLC transformation PDX and clinical settings
doi 10.3389/fonc.2025.1661273
- 558 views
3,632
Total downloads
14k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
CASE REPORT
Published on 08 Oct 2025
ORIGINAL RESEARCH
Published on 01 Sep 2025
ORIGINAL RESEARCH
Published on 30 May 2025
REVIEW
Published on 22 Jan 2025
CASE REPORT
Published on 22 Jan 2025
CASE REPORT
Published on 11 Dec 2024
REVIEW
Published on 15 May 2024
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: